Skip to main content

Table 1 Absolute numbers and proportions of the different pneumococcal serotypes, according to they were included or not in the 23-valent polysaccharide pneumococcal vaccine (PPV) identified among case patients (n = 53).

From: Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

S. pneumonia serotype N (%)
Serotypes included in 23-valent PPV  
   1 6 (11.3)
   3 7 (13.2)
   4 3 (5.6)
   5 2 (3.8)
   6B 3 (5.6)
   7F 3 (5.6)
   8 4 (7.5)
   9V 2 (3.8)
   12F 1 (1.9)
   14 8 (15.1)
   15B 1 (1.9)
   19A 2 (3.8)
   19F 2 (3.8)
Vaccine-related serotypes  
   6A 2 (3.8)
   23A 2 (3.8)
Non-vaccine serotypes  
   13 1 (1.9)
   16 1 (1.9)
   31 2 (3.8)
   38 1 (1.9)